Vivos Inc. (OTCMKTS:RDGL – Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 59,400 shares, a drop of 42.9% from the March 31st total of 104,000 shares. Based on an average daily trading volume, of 3,214,800 shares, the days-to-cover ratio is currently 0.0 days.
Vivos Stock Up 25.1 %
OTCMKTS:RDGL traded up $0.03 during trading hours on Friday, hitting $0.15. 2,763,974 shares of the company were exchanged, compared to its average volume of 759,674. Vivos has a 52-week low of $0.04 and a 52-week high of $0.16. The company’s 50 day moving average price is $0.08 and its 200-day moving average price is $0.07.
Vivos (OTCMKTS:RDGL – Get Free Report) last posted its earnings results on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter.
Vivos Company Profile
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Further Reading
- Five stocks we like better than Vivos
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks Leading the U.S. Agriculture Comeback
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Best Aerospace Stocks Investing
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
